Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length | Zendy

Hans Krankenberg | Zendy; Michael Schlüter | Zendy; Hermann Steinkamp | Zendy; Karlheinz Bürgelin | Zendy; Dierk Scheinert | Zendy; Karl-Ludwig Schulte | Zendy; Erich Minar | Zendy; Patrick Peeters | Zendy; Marc Bosiers | Zendy; Gunnar Tepe | Zendy; Bernhard Reimers | Zendy; F Mahler | Zendy; Thilo Tübler | Zendy; Thomas Zeller | Zendy

Open Access

Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length

Author(s) -

Hans Krankenberg,

Michael Schlüter,

Hermann Steinkamp,

Karlheinz Bürgelin,

Dierk Scheinert,

Karl-Ludwig Schulte,

Erich Minar,

Patrick Peeters,

Marc Bosiers,

Gunnar Tepe,

Bernhard Reimers,

F Mahler,

Thilo Tübler,

Thomas Zeller

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.689141

Subject(s) - medicine , restenosis , angioplasty , lesion , percutaneous , femoral artery , surgery , stent , stenosis , radiology , revascularization , target lesion , cardiology , percutaneous coronary intervention , myocardial infarction

Endoluminal treatment of superficial femoral artery lesions is a matter of controversy. The present study was designed to investigate the impact of nitinol stenting of superficial femoral artery lesions with a maximum length of 10 cm on restenosis and clinical outcomes at 1 year.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research